Lurosetron
Lurosetron (INN) is a serotonin 5-HT3 receptor antagonist.[1]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H17FN4O |
Molar mass | 312.348 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Synthesis
![](../I/m/Lurosetron_synthesis.svg.png)
Lurosetron synthesis: EP 0353983
gollark: ++achieve test
gollark: ++magic sql delete from achievements where achievement = 'test'
gollark: <@160279332454006795>
gollark: Go achieve test.
gollark: You can get... test?
References
- Prakash SP, Cable KM, Correa ID, Fellows L, Montgomery S, Newman JJ, Waterhouse L, Wells GN, Sutherland DR. Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists. Journal of Labelled Compounds and Radiopharmaceuticals. 1995; 36(10):993-1007.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.